Advertisement

Topics

ANDA Sponsors Face Tight Controls On Meetings With US FDA After CR Letters

13:51 EST 12 Dec 2018 | SCRIP

Meetings are intended to help generic sponsors understand deficiencies, but agency won't let them run past 30 minutes.

      

Related Stories

 

Original Article: ANDA Sponsors Face Tight Controls On Meetings With US FDA After CR Letters

NEXT ARTICLE

More From BioPortfolio on "ANDA Sponsors Face Tight Controls On Meetings With US FDA After CR Letters"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...